Remove contact
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – June

SQA

On 09 May 2022, NMPA released the draft of the revised Regulations for Implementation of the Drug Administration Law (hereafter referred to as the Regulations ) for public comments. The Regulations were first issued with immediate effect in 2002 and were later revised in 2016.

FDA 91
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

The deadline for reporting serious incidents not constituting serious public health threats, deaths, or unanticipated serious deteriorations in state of health was reduced to 15 calendar days. The Therapeutic Goods (Medical Devices) Regulations 2002 now includes for Essential Principle 7.7: Products that are injected.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

It will also facilitate cross-border circulation of these critical health therapies as well as cross-border cooperation between public health authorities. This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells.

FDA 40
article thumbnail

FDA Oversight of AI Software Developed by Health Care Providers

Health Law Advisor

FDA came out with guidance explicitly explaining its reach over hospitals engaged in those reprocessing efforts, [14] and in 2002 Congress validated that extension with an amendment to the underlying statute. [15] FDA serves an important public health purpose of externally validating algorithms that impact patient care.

FDA 98
article thumbnail

SQA Regulatory Surveillance Summary 5 | Monthly Update 2021

SQA

ISO 10651-4:2002, Lung ventilators – Part 4: Particular requirements for operator-powered resuscitators. Greater API production domestically will help reduce reliance on global supply chains for medications that are in shortage, particularly during times of increased public health need.

FDA 83
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

Anyone feeling unwell, for example with symptoms of eye infection, such as reduced vision or red and painful eyes, should contact a healthcare professional and tell them that they have been using a recalled eye gel. These are requirements of the Therapeutic Goods (Medical Devices) Regulations 2002.

FDA 52